CLINICAL_TRIALS
trial_result
· 2021-02-02
Clinical Trial Update: A Study of the Safety of Gabapentin in a Potential Over-the-Counter Population With Occasional Sleeplessness [Phase 3]
Summary
Phase 3 study assessing the safety of gabapentin for occasional sleeplessness in a potential OTC population has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Transient Insomnia | Phase 3 | Status: COMPLETED